Mutism in older adults is not uncommon. It is often confused with severe depression, locked-in syndrome, and persistent vegetative state, but it is important to distinguish among them as the ...

Autoimmune bullous diseases are often associated with significant morbidity and some can even cause mortality, if left untreated. Multiple therapies are now available to treat these blistering ...

Anemia is highly prevalent in patients with chronic heart failure (HF) and is associated with poor clinical outcomes. Multiple mechanisms contribute to anemia in chronic HF, and subnormal ...

The clinical spectrum of intestinal E. histolytica infection ranges from an asymptomatic carrier state to severe invasive disease. Asymptomatic cyst carriage occurs with E. histolytica as well as E.

Despite numerous therapeutic research efforts, treatment of BV remains cumbersome and clinicians are currently rather poorly armed to treat BV properly in the long run. Moreover, appraisal of the ...

Purpose: The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosage and administration of pregabalin are reviewed. Summary: Pregabalin is the first drug to receive approved ...

Purpose. The efficacy and safety of granulocyte colony-stimulating factor (G-CSF) in critically ill patients with severe sepsis or septic shock were evaluated. Summary. The medical literature was ...

For patients with chronic viral hepatitis, clinicians instinctively rely on liver enzyme measurements to estimate disease activity and assess need for liver biopsy or antiviral treatment.

Orthoses are widely used in the management of children with CP even though there is no robust evidence for its effect. [8,9] The ankle-foot orthosis (AFO) is the most frequently used type of ...

Histologically (Figure 2), elongated dendritic melanocytes are scattered widely in the papillary to mid reticular dermis. These melanocytes stain weakly with 3,4-dihydroxyphenylalanine, which ...

Cataract surgery may not increase the risk for postoperative endophthalmitis or severe systemic adverse events in patients ...

AMSTERDAM — A once daily, 50 mg dose of efruxifermin reduced fibrosis at 96 weeks in patients with compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis (MASH) compared with ...